Eterna Therapeutics News

10-Q: Quarterly report

SEC announcementMay 15 05:20 · Announcements

Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) IMSC Line With Enhanced Immunosuppressive Activity and Stealthing Features That May Further Augment the Therapeutic Potential of...

The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive activity and stealthing features that may further augment the therapeutic potential of MSCs

GlobeNewswireMay 10 20:00

Press Release: Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to Its Scientific Advisory Board

Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ("Eterna" o

Dow JonesMay 8 21:31

Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to Its Scientific Advisory Board

Yahoo FinanceMay 8 21:31

Eterna Therapeutics To Present at The ASGCT 27th Annual Meeting On Development Of Beta 2 Microglobulin-Knockout IMSC Line With Enhanced Immunosuppressive Activity And Stealthing Features

Eterna Therapeutics To Present at The ASGCT 27th Annual Meeting On Development Of Beta 2 Microglobulin-Knockout IMSC Line With Enhanced Immunosuppressive Activity And Stealthing Features

BenzingaMay 7 20:04

Factor Bioscience Expands Translational Science Team, Appoints Kyle Garland, Ph.D., as Director of Translational Science

CAMBRIDGE, Mass., April 9, 2024 /PRNewswire/ -- Factor Bioscience Inc. ("Factor"), a Cambridge, Massachusetts-based biotechnology company developing advanced mRNA and cell-engineering technologies, t

PR NewswireApr 9 19:30

Earnings Week Ahead: Walgreens Boots Alliance, Carnival, GameStop and More

Seeking AlphaMar 24 20:01

Eterna Therapeutics Inc On March 19, Received A Notice From Nasdaq Stating That Co Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)

Eterna Therapeutics Inc On March 19, Received A Notice From Nasdaq Stating That Co Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)

BenzingaMar 23 04:37

Press Release: Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to Its Board of Directors

Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ("Eterna" or t

Dow JonesFeb 20 21:30

Eterna Therapeutics Welcomes New Board Member Peter Cicala

TipRanksFeb 16 20:42

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersRevance Therapeutics (NASDAQ:RVNC) shares moved upwards by 16.5% to $6.0 during Friday's pre-market session. The company's market cap stands at $526.8 million. Eterna Therapeutics (NASDAQ:ERNA)

BenzingaFeb 2 21:06

Eterna Therapeutics Files to Sell 18.2M Shares for Holders

Seeking AlphaJan 13 05:56

Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (C)(4)

CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (NASDAQ:ERNA) ("Eterna" or the "Company"), a life science company committed to realizing the potential of mRNA cell engineering to provide

GlobeNewswireJan 4 05:15

Eterna Therapeutics Appoints Sanjeev Luther as President and CEO

Yahoo FinanceDec 22, 2023 00:18

Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer

CAMBRIDGE, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (NASDAQ:ERNA) ("Eterna" or the "Company"), a life science company committed to realizing the potential of mRNA cell engineering to provide

GlobeNewswireDec 21, 2023 05:15

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

GainersAclarion (NASDAQ:ACON) shares rose 75.8% to $0.51 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.8 million. Longeveron (NASDAQ:LGVN) stock rose 43.

BenzingaDec 20, 2023 21:07

Eterna Therapeutics Launches Convertible Debt and Warrant Financing of up to $9.2M

Seeking AlphaDec 16, 2023 01:37

Eterna Therapeutics Announces $9.2M Convertible Debt And Warrant Financing

Eterna Therapeutics Inc. a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the execution of

BenzingaDec 15, 2023 15:00

Press Release: Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing

Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing CAMBRIDGE, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) ("Eterna" or the "Compan

Dow JonesDec 15, 2023 07:56

12 Health Care Stocks Moving In Tuesday's Intraday Session

GainersC4 Therapeutics (NASDAQ:CCCC) stock increased by 100.5% to $2.37 during Tuesday's regular session. The market value of their outstanding shares is at $116.6 million. Aditxt (NASDAQ:ADTX) shares

BenzingaDec 13, 2023 01:31